Nasenspray (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride selectively stimulates alpha‑1 adrenergic receptors on the smooth muscle of nasal blood vessels. This activation causes vasoconstriction, which reduces blood flow to the nasal mucosa, decreasing edema and mucus formation. The resulting narrowing of the vessels opens the nasal airway and eases congestion.

The exact dosing regimen is determined by the prescribing healthcare professional. Typically, adults may use one to two sprays per nostril every 8‑10 hours, not exceeding the maximum daily frequency indicated on the product label. Children’s dosing, if permitted, follows the prescriber’s guidance and should not exceed the recommended duration of three to five days.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Nasenspray. The prescriber may recommend alternative treatments if concerns arise.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing a formal quotation, availability, shipping details, and any necessary import documentation.

Both Xylometazoline and oxymetazoline belong to the imidazoline class and act as alpha‑adrenergic agonists, offering rapid relief of nasal congestion. Xylometazoline typically has a slightly longer duration of action, allowing dosing every 8‑10 hours, whereas oxymetazoline may require more frequent dosing. Clinical choice often depends on patient tolerance, local availability, and prescriber preference.

Store Nasenspray at room temperature, ideally below 25 °C, in its original container. Keep the bottle tightly closed when not in use, protect it from moisture, direct sunlight, and extreme temperatures. Do not freeze the product, and keep it out of reach of children.

Nasenspray is applied directly into each nostril. Before use, gently blow the nose to clear excess mucus. Tilt the head slightly forward, insert the nozzle into one nostril, and press the pump to deliver the prescribed number of sprays. Repeat in the other nostril if required, then avoid blowing the nose for a few minutes to allow absorption.

Serious risks include rebound nasal congestion (rhinitis medicamentosa) after prolonged use, severe hypertension, cardiac arrhythmias, and rare allergic reactions such as rash, angioedema, or nasal ulceration. Patients experiencing any of these symptoms should discontinue use immediately and seek medical attention.

Nasenspray should be avoided by individuals with known hypersensitivity to Xylometazoline or any formulation component, children under six years of age unless specifically directed by a clinician, and patients with uncontrolled hypertension, severe cardiovascular disease, or those already using other topical nasal decongestants.